These 5 Drug/Biotech Stocks Have The Combination To Unlock An Earnings Surprise
Amid a third-quarter earnings season that has been a mixed bag of beats and misses for drug/biotech companies, today’s article highlights five drug/biotech stocks that…
davidgoldstein
These 3 Biotechs Have Different Approaches To A COVID-19 Vaccine, But The Same Analyst Rating: ‘Buy’
An intranasal vaccine, an mRNA vaccine, and a T-cell activation vaccine: the three biotech companies discussed in today’s article are approaching the virus that causes…
This Biotech Stock Could Be A Good “Bad News Buy”
When it comes to the biotech stock that’s the focus of today’s article, which plummeted in mid-October when the company abruptly pulled the plug on…
These Biotechs Are Awaiting FDA Rulings In November
October has seen the FDA approve the first drug for COVID-19 (remdesivir), the first treatment for Ebola virus (Regeneron Pharmaceuticals’ Inmazeb), and the first drug…
Consider Excising These “Unhealthy” Biotech Stocks From Your Portfolio
When it comes to the seven “unhealthy” biotech stocks that are the focus of today’s article, the author advises the following: “While these aren’t terrible…
Is The Stage Being Set For A Strong Biotech Rally?
Amid setbacks for various potential COVID-19 vaccines and treatments, election risk, strengthening M&A activity, and more, what’s the outlook for healthcare and biotech in the…
The Current Status – And Future Prospects – Of This COVID-19 Vaccine Partnership
In March, two small biotechs partnered to develop a vaccine for COVID-19 using a mechanism called RNA interference (RNAi) – and early data for the…
How To Speculate On This Biotech Stock With “A Historically Bullish Signal Flashing”
The biotech stock highlighted in today’s article is already up 173% so far this year, and now the author advises that “a historically bullish signal…
This Biotech Stock Has High Return Potential – And A Potential Bump In The Road
The biotech company highlighted in today’s article, specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer, is one that…
Biggest Biotech Bargains
“Although the vast majority of biotech stocks are losing money, a handful of these profitable drug developers are valued at levels that make them absolute…